MTOR and breast carcinoma: Conversely, reducing OGT levels or O-GlcNAcylation in breast cancer cells leads to inhibition of mTOR activity as measured by phosphorylation of ribosomal protein S6 kinase beta-1 (p70S6K) [47], an mTOR target.